These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27769334)

  • 1. Generic glaucoma drop bottle cap colours.
    Hallaji NAE; Trope GE
    Can J Ophthalmol; 2016 Oct; 51(5):392-393. PubMed ID: 27769334
    [No Abstract]   [Full Text] [Related]  

  • 2. The Utility of Cap Color and Bottle Characteristics for Topical Glaucoma Therapy.
    Marando CM; Seibold LK; SooHoo JR; Pantcheva MB; Ramulu PY; Kahook MY
    Ophthalmology; 2015 Dec; 122(12):2577-8. PubMed ID: 26077575
    [No Abstract]   [Full Text] [Related]  

  • 3. Ability of Bottle Cap Color to Facilitate Accurate Patient-Physician Communication Regarding Medication Identity in Patients with Glaucoma.
    Dave P; Villarreal G; Friedman DS; Kahook MY; Ramulu PY
    Ophthalmology; 2015 Dec; 122(12):2373-9. PubMed ID: 26260280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bottle Characteristics of Topical International Glaucoma Medications versus Local Brands in Saudi Arabia.
    Al-Jumaian N; Malik R; Khandekar R; Al-Humaidan A; Al-Madany R; Al-Qahtani R; Altowairqi A; Al-Theeb A; Zaman B; Al-Djasim L; Craven ER; Edward DP
    Middle East Afr J Ophthalmol; 2016; 23(4):296-301. PubMed ID: 27994392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Factors and Ophthalmic Drug Packaging: Time for a Global Standard.
    Brandt JD
    Ophthalmology; 2015 Dec; 122(12):2368-70. PubMed ID: 26592669
    [No Abstract]   [Full Text] [Related]  

  • 6. Generic versus brand-name North American topical glaucoma drops.
    Mammo ZN; Flanagan JG; James DF; Trope GE
    Can J Ophthalmol; 2012 Feb; 47(1):55-61. PubMed ID: 22333853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in Number of Doses, Bottle Volume, and Calculated Yearly Cost of Generic and Branded Latanoprost for Glaucoma.
    Queen JH; Feldman RM; Lee DA
    Am J Ophthalmol; 2016 Mar; 163():70-74.e1. PubMed ID: 26596398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosage variability of topical ocular hypotensive products: a densitometric assessment.
    Gaynes BI; Singa RM; Cao Y
    J Glaucoma; 2009 Feb; 18(2):149-52. PubMed ID: 19225353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squeeze Me if You Can: Variability in Force Requirements to Extract a Drop From Common Glaucoma Bottles.
    Moore DB; Hammer JD; Akhtari R; Beck J; Sanders S; Kryscio RJ
    J Glaucoma; 2016 Sep; 25(9):780-4. PubMed ID: 27552516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drop instillation and glaucoma.
    Davis SA; Sleath B; Carpenter DM; Blalock SJ; Muir KW; Budenz DL
    Curr Opin Ophthalmol; 2018 Mar; 29(2):171-177. PubMed ID: 29140818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generic drugs in glaucoma therapy, a new reality to deal with.
    De Natale R; Gandolfi SA
    Clin Exp Ophthalmol; 2013 Aug; 41(6):622-4. PubMed ID: 23278970
    [No Abstract]   [Full Text] [Related]  

  • 12. Black eye drop bottle tips improve compliance.
    Stack RR; McKellar MJ
    Clin Exp Ophthalmol; 2004 Feb; 32(1):39-41. PubMed ID: 14746589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An objective assessment of the variability in number of drops per bottle of glaucoma medication.
    Moore DB; Beck J; Kryscio RJ
    BMC Ophthalmol; 2017 May; 17(1):78. PubMed ID: 28532424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating eye drop instillation technique in glaucoma patients.
    Gupta R; Patil B; Shah BM; Bali SJ; Mishra SK; Dada T
    J Glaucoma; 2012 Mar; 21(3):189-92. PubMed ID: 21336146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study.
    Boland MV; Chang DS; Frazier T; Plyler R; Friedman DS
    JAMA Ophthalmol; 2014 Jul; 132(7):838-44. PubMed ID: 24830878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a short version of the glaucoma medication self-efficacy questionnaire.
    Sleath B; Blalock SJ; Stone JL; Skinner AC; Covert D; Muir K; Robin AL
    Br J Ophthalmol; 2012 Feb; 96(2):258-62. PubMed ID: 21610264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eye Drop Adherence With an Eye Drop Bottle Cap Monitor.
    Kinast RM; Sanchez FG; Rees JP; Yeh K; Gardiner SK; Dawes J; Johnston ML; Porter JD; Klei V; Mansberger SL
    J Glaucoma; 2023 May; 32(5):369-373. PubMed ID: 37053080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real advantages of preservative-free preparations in special containers for long-term glaucoma therapy.
    Boles Carenini B; Boldrini E; Brogliatti B
    Acta Ophthalmol Scand Suppl; 2002; 236():57-9. PubMed ID: 12390147
    [No Abstract]   [Full Text] [Related]  

  • 19. Multicenter study of compliance and drop administration in glaucoma.
    Kholdebarin R; Campbell RJ; Jin YP; Buys YM
    Can J Ophthalmol; 2008 Aug; 43(4):454-61. PubMed ID: 18711461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-administration of eye drops. a patient's view.
    Gebhardt DO
    Am J Ophthalmol; 2003 Oct; 136(4):778; author reply 778. PubMed ID: 14516846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.